BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28043707)

  • 1. Salvage Lymph Node Dissection for Node-only Recurrence of Prostate Cancer: Ready for Prime Time?
    Suardi N; Briganti A; Gandaglia G; Fossati N; Montorsi F
    Eur Urol; 2017 May; 71(5):693-694. PubMed ID: 28043707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.
    Suardi N; Gandaglia G; Gallina A; Di Trapani E; Scattoni V; Vizziello D; Cucchiara V; Bertini R; Colombo R; Picchio M; Giovacchini G; Montorsi F; Briganti A
    Eur Urol; 2015 Feb; 67(2):299-309. PubMed ID: 24571959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.
    Winter A; Henke RP; Wawroschek F
    BMC Urol; 2015 Feb; 15(1):10. PubMed ID: 25881245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy.
    Oderda M; Joniau S; Palazzetti A; Falcone M; Melloni G; Van Den Bossche H; Deconinck S; Zattoni F; Karnes RJ; Gontero P
    Eur Urol Focus; 2018 Mar; 4(2):288-293. PubMed ID: 30205893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical Management.
    Linxweiler J; Sprenk J; Cascetta K; Pryalukhin A; Hölters S; Zeuschner P; Nini A; Al-Kailani Z; Ezziddin S; Bohle RM; Fries P; Ohlmann CH; Heinzelbecker J; Siemer S; Stöckle M; Junker K; Saar M
    J Urol; 2021 Jul; 206(1):88-96. PubMed ID: 33617326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.
    Karnes RJ; Murphy CR; Bergstralh EJ; DiMonte G; Cheville JC; Lowe VJ; Mynderse LA; Kwon ED
    J Urol; 2015 Jan; 193(1):111-6. PubMed ID: 25150640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series.
    Bravi CA; Fossati N; Gandaglia G; Suardi N; Mazzone E; Robesti D; Osmonov D; Juenemann KP; Boeri L; Jeffrey Karnes R; Kretschmer A; Buchner A; Stief C; Hiester A; Nini A; Albers P; Devos G; Joniau S; Van Poppel H; Shariat SF; Heidenreich A; Pfister D; Tilki D; Graefen M; Gill IS; Mottrie A; Karakiewicz PI; Montorsi F; Briganti A
    Eur Urol; 2020 Dec; 78(6):779-782. PubMed ID: 32624281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific membrane antigen-guided salvage lymph node dissection in recurrent prostate cancer: a novel technology to detect lymph node metastases.
    Maurer T; Gschwend JE; Eiber M
    Curr Opin Urol; 2018 Mar; 28(2):191-196. PubMed ID: 29028767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of
    Fossati N; Scarcella S; Gandaglia G; Suardi N; Robesti D; Boeri L; Karnes RJ; Heidenreich A; Pfister D; Kretschmer A; Buchner A; Stief C; Battaglia A; Joniau S; Van Poppel H; Osmonov D; Juenemann KP; Shariat S; Hiester A; Nini A; Albers P; Tilki D; Graefen M; Gill IS; Mottrie A; Galosi AB; Montorsi F; Briganti A
    J Urol; 2020 Aug; 204(2):296-302. PubMed ID: 32068488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage Pelvic Lymph Node Dissection and Current State of Imaging for Recurrent Prostate Cancer: Does a Standard Exist?
    McCloskey H; Jacobs J; Zambrano I; Moore T; Khandani AH; Bjurlin MA
    Curr Urol Rep; 2020 Nov; 21(12):62. PubMed ID: 33159608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage lymph node dissection in patients with prostate cancer treated with radical prostatectomy or radiotherapy and positive choline positron emission tomography (PET/CT) scan.
    Otta-Oshiro RJ; Lista-Mateos F; García-Mediero J; Arranz-Arija JA; García-Prado J; Núñez-Mora C
    Actas Urol Esp (Engl Ed); 2019; 43(6):331-335. PubMed ID: 30975547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastases-yield and Prostate-specific Antigen Kinetics Following Salvage Lymph Node Dissection for Prostate Cancer: A Comparison Between Conventional Surgical Approach and Prostate-specific Membrane Antigen-radioguided Surgery.
    Knipper S; Tilki D; Mansholt J; Berliner C; Bernreuther C; Steuber T; Maurer T; Graefen M
    Eur Urol Focus; 2019 Jan; 5(1):50-53. PubMed ID: 30292421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy.
    Abdollah F; Briganti A; Montorsi F; Stenzl A; Stief C; Tombal B; Van Poppel H; Touijer K
    Eur Urol; 2015 May; 67(5):839-49. PubMed ID: 24698524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy.
    Tilki D; Mandel P; Seeliger F; Kretschmer A; Karl A; Ergün S; Seitz M; Stief CG
    J Urol; 2015 Feb; 193(2):484-90. PubMed ID: 25180792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
    BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes.
    Linxweiler J; Saar M; Al-Kailani Z; Janssen M; Ezziddin S; Stöckle M; Siemer S; Ohlmann CH
    Surg Oncol; 2018 Jun; 27(2):138-145. PubMed ID: 29937163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extended salvage pelvic and retroperitoneal lymph node dissection due to prostate cancer relapse].
    Osmonov DK; Aksenov AV; Jünemann KP
    Aktuelle Urol; 2013 Jan; 44(1):50-2. PubMed ID: 23325670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival.
    Nini A; Gandaglia G; Fossati N; Suardi N; Cucchiara V; Dell'Oglio P; Cazzaniga W; Luzzago S; Montorsi F; Briganti A
    Eur Urol; 2015 Nov; 68(5):777-84. PubMed ID: 25959166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy.
    Van Eecke H; Devos G; Vansevenant B; Vander Stichele A; Devlies W; Berghen C; Everaerts W; De Meerleer G; Joniau S
    Int J Urol; 2023 Jan; 30(1):92-99. PubMed ID: 36305586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer.
    Jilg CA; Rischke HC; Reske SN; Henne K; Grosu AL; Weber W; Drendel V; Schwardt M; Jandausch A; Schultze-Seemann W
    J Urol; 2012 Dec; 188(6):2190-7. PubMed ID: 23083862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.